ArticleClinical oral investigations2026
Translation and validation of the Hebrew version of the xerostomia inventory.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesXerostomia significantly affects oral health and quality of life, yet no validated Hebrew assessment exists. This study aimed to translate the Xerostomia Inventory (XI) into Hebrew (HXI) and evaluate its validity and reliability.
methodsThe XI was translated into Hebrew using cross-cultural adaptation guidelines. The HXI was examined for internal consistency, using Cronbach's alpha, as well as for construct validity (convergent and discriminant validity).
resultsThe HXI was completed by 102 xerostomia patients, 89.2% women, and the mean age was 63.5 ± 13.8 years with age range of 20-90 years. The mean HXI score was 39.9 ± 1.2, with score range 12-55. The HXI exhibited a high level of reliability with Cronbach's α = 0.975. The convergent validity of the HXI, indicated by Spearman's correlation between the HXI and the unstimulated salivary flow (USF) whole volume, demonstrated a strong, negative, and statistically significant correlation (r = -0.862). Strong negative correlations were also found between the total HXI score and other sialometry variables (ranging from r=-0.696 to r=-0.879). The absence of significant associations between the HXI scores and unrelated sociodemographic variables supports the discriminant validity of the HXI. Confirmatory factor analysis supported a robust unidimensional structure for the Hebrew 11-item HXI, with a single factor accounting for 80.3% of the total variance and all item loadings exceeding 0.82.
conclusionsThe HXI is a valid and reliable instrument for assessing xerostomia in Hebrew-speaking populations, demonstrating psychometric robustness consistent with international versions. CLINICAL RELEVANCE: The HXI provides a valid and reliable tool for assessing patient-reported oral dryness, supporting diagnosis, treatment, and evaluation of interventions in Hebrew-speaking populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.